- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
June 6, 2023Super Lawyers Names Five Attorneys to “Southern California Rising Stars” List
-
June 1, 2023Chambers USA Recognizes Five Robins Kaplan Practice Groups and 17 Lawyers in 2023 Guide
-
May 2023Robins Kaplan LLP Celebrates 85 Years
-
June 9, 2023LGBTQ Legal Services: Transgender Name Change Clinic
-
June 13, 20232023 Probate and Trust Law Section Conference
-
June 14, 2023Leading Through Uncertainty
-
May 2023Raoul Shah: Keeping Humanity and Compassion Close
-
May 18, 2023NFT Trademark Defense Comes Down To Licensing Terms
-
April 20, 2023Drafting Subsequent Agreements to Avoid Arbitrability Litigation
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Obtained $589 Million Settlement in Landmark National Opioid Litigation on Behalf of Tribal Nations
A Historic First in Tribal Government Litigation
March 2022
In Re: National Prescription Opiate Litigation, 17-cv-2804 (N.D. Ohio)
Robins Kaplan represented 28 Tribal Nations asserting that the manufacturers of prescription opioids grossly misrepresented the risks of long-term use of those drugs for persons with chronic pain, and distributors failed to properly monitor suspicious orders of those prescription drugs, all of which contributed to the current opioid epidemic.
The firm, as part of the Tribal Leadership Committee, secured an initial total settlement of $589 Million on behalf of all federally recognized Tribes.
The firm secured a $439 million settlement of the national opioid litigation claims by Tribes brought against AmerisourceBergen Corp., McKesson Corp., Cardinal Health, Inc. (“Distributors”).
The firm also secured a $150 million settlement of the national opioid litigation claims by Tribes brought against Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica, Inc. N/K/A Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., N/K/A Janssen Pharmaceuticals, Inc. (“Janssen”).
This case and these initial settlements represent a historic first in Tribal governments litigating together to exercise their sovereignty.
Related Professionals
Holly H. Dolejsi
Partner
Deputy Chair, Mass Tort, Personal Injury and Medical Malpractice Groups
Chair, Women of Robins Kaplan Resource Group
Pronouns: she/her
Timothy Q. Purdon
Partner
Co-Chair, American Indian Law and Policy Group;
Co-Chair, Government and Internal Investigations Group
Brendan V. Johnson
Partner
Co-Chair, American Indian Law and Policy Group;
Co-Chair, Government and Internal Investigations Group
Similar Results
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.